<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Seiwert</surname>
   <given-names>SD</given-names>
  </name>
  <name>
   <surname>Andrews</surname>
   <given-names>SW</given-names>
  </name>
  <name>
   <surname>Jiang</surname>
   <given-names>Y</given-names>
  </name>
  <name>
   <surname>Serebryany</surname>
   <given-names>V</given-names>
  </name>
  <name>
   <surname>Tan</surname>
   <given-names>H</given-names>
  </name>
  <name>
   <surname>Kossen</surname>
   <given-names>K</given-names>
  </name>
  <name>
   <surname>Rajagopalan</surname>
   <given-names>PT</given-names>
  </name>
  <name>
   <surname>Misialek</surname>
   <given-names>S</given-names>
  </name>
  <name>
   <surname>Stevens</surname>
   <given-names>SK</given-names>
  </name>
  <name>
   <surname>Stoycheva</surname>
   <given-names>A</given-names>
  </name>
  <article-title>Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</article-title>
  <source>Antimicrob Agents Chemother</source>
  <year>2008</year>
  <volume>52</volume>
  <fpage>4432</fpage>
  <lpage>4441</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00699-08</pub-id>
  <pub-id pub-id-type="pmid">18824605</pub-id>
 </mixed-citation>
</ref>
